Contraception in HIV-positive women
McCormack, C.D.; Gunston, K.D.
South African Medical Journal 85(12): 1303
1995
ISSN/ISBN: 0256-9574 PMID: 8600594 Document Number: 444925
Document emailed within 1 workday
Related Documents
Kancheva Landolt, N.; Ramautarsing, R.A.; Phanuphak, N.; Teeratakulpisarn, N.; Pinyakorn, S.; Rodbamrung, P.; Chaithongwongwatthana, S.; Ananworanich, J. 2013: Factors associated with the use of irreversible contraception and continuous use of reversible contraception in a cohort of HIV-positive women Contraception 88(1): 67-73Kancheva Landolt, N.; Ramautarsing, R.A.; Phanuphak, N.; Teeratakulpisarn, N.; Pinyakorn, S.; Rodbamrung, P.; Chaithongwongwatthana, S.; Ananworanich, J. 2013: Factors associated with the use of irreversible contraception and continuous use of reversible contraception in a cohort of HIV-positive women Contraception 88(1): 67-73
Womack, J.; Williams, A. 2008: Hormonal contraception in HIV-positive women Aids Reader 18(7): 372-377; 381
Mitchell, H.S.; Stephens, E. 2004: Contraception choice for HIV positive women Sexually Transmitted Infections 80(3): 167-173
Cocohoba, J. 2010: Hormonal contraception for HIV positive women Beta: Bulletin of Experimental Treatments for Aids: a Publication of the San Francisco Aids Foundation 22(2): 36-40
Okunola, T.O.; Ijaduola, K.T.; Adejuyigbe, E.A. 2019: Unmet need for contraception among HIV-positive women in Ile-Ife, Nigeria Tropical Doctor 49(1): 26-31
Samuel, M.I.; Welch, J.; Tenant-Flowers, M.; Brady, M.; Poulton, M.; Savvas, M.; Kumar, U.; Taylor, C. 2008: Contraception and medical gynaecology for HIV-positive women in a one-stop clinic International Journal of Std and Aids 19(8): 559-560
Stanwood, N.L.; Cohn, S.E.; Heiser, J.R.; Pugliese, M. 2007: Contraception and fertility plans in a cohort of HIV-positive women in care Contraception 75(4): 294-298
Mbonye, A.K.; Hansen, K.S.; Wamono, F.; Magnussen, P. 2012: Barriers to contraception among HIV-positive women in a periurban district of Uganda International Journal of Std and Aids 23(9): 661-666
Womack, J.; Richman, S.; Tien, P.C.; Grey, M.; Williams, A. 2008: Hormonal contraception and HIV-positive women: metabolic concerns and management strategies Journal of Midwifery and Women's Health 53(4): 362-375
Adair, T. 2008: Unmet need for contraception among HIV-positive women in Lesotho and implications for mother-to-child transmission Journal of Biosocial Science 41(2): 269-278
Atrio, J.; Stek, A.; Vora, H.; Sanchez-Keeland, L.; Zannat, F.; Natavio, M. 2015: The effect of protease inhibitors on the cervical mucus of HIV-positive women taking norethindrone contraception European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 20(2): 149-153
Adedimeji, A.A.; Hoover, D.R.; Shi, Q.; Cohen, M.H.; Gard, T.; Anastos, K. 2012: Differences in the Nonuse of any Contraception and use of Specific Contraceptive Methods in HIV Positive and HIV Negative Rwandan Women Aids Research and Treatment 2012: 367604
Kakaire, O.; Byamugisha, J.K.; Tumwesigye, N.M.; Gamzell-Danielsson, K. 2015: Prevalence and factors associated with sexually transmitted infections among HIV positive women opting for intrauterine contraception Plos one 10(4): E0122400
Comtet, M.; Chabbertbuffet, N. 2013: Contraception après cancer: balance bénéfice/risque pour une contraception adaptée et acceptée : Grossesses, contraception, fertilité et cancer - Contraceptive choice after cancer: adapted and well accepted to reach a positive riskbenefit balance : Pregnancy, contraception, fertility and cancer Oncologie (Paris) 15(5): 243-250
Comtet, M.; Chabbertbuffet, N. 2013: Contraception après cancer: balance bénéfice/risque pour une contraception adaptée et acceptée : Grossesses, contraception, fertilité et cancer - Contraceptive choice after cancer: adapted and well accepted to reach a positive riskbenefit balance : Pregnancy, contraception, fertility and cancer Oncologie (Paris) 15(5): 243-250
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5